Clinical Trial Update: A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2a clinical trial evaluating UV1 vaccination in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• UV1 vaccine (UV1 vaccine)

Snippet

Sponsor: Ultimovacs ASA | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED